Calculates the HCT-CI score, a tool designed to assess comorbidities in patients undergoing hematopoietic cell transplantation. It predicts non-relapse mortality (NRM) and overall survival better than the Charlson Comorbidity Index in this population.
hct_ci_score(arrhythmia, cardiac_comorbidity, ibd, diabetes, cerebrovascular,
psychiatric, hepatic_mild, hepatic_severe, obesity, infection,
rheumatologic, peptic_ulcer, renal_moderate_severe,
pulmonary_moderate, pulmonary_severe, prior_solid_tumor,
heart_valve_disease)A list containing:
The calculated score (Range 0-27+).
Classification (Low 0, Intermediate 1-2, High >=3).
Estimated 2-year NRM percentage.
Estimated 2-year Overall Survival percentage.
Numeric (0 or 1). Atrial fibrillation/flutter, sick sinus syndrome, or ventricular arrhythmias. (1 pt).
Numeric (0 or 1). Coronary artery disease, CHF, MI, or EF < 50%. (1 pt).
Numeric (0 or 1). Inflammatory bowel disease (Crohn's/UC). (1 pt).
Numeric (0 or 1). Diabetes or steroid-induced hyperglycemia requiring treatment. (1 pt).
Numeric (0 or 1). TIA or CVA. (1 pt).
Numeric (0 or 1). Depression/anxiety requiring psychiatric consult or treatment. (1 pt).
Numeric (0 or 1). Mild hepatic disease (Bilirubin > ULN to 1.5x ULN, or AST/ALT > ULN to 2.5x ULN). (1 pt).
Numeric (0 or 1). Moderate/Severe hepatic disease (Bili > 1.5x ULN, AST/ALT > 2.5x ULN, or cirrhosis). (3 pts).
Numeric (0 or 1). BMI > 35 kg/m^2. (1 pt).
Numeric (0 or 1). Infection requiring continuation of antimicrobials after day 0. (1 pt).
Numeric (0 or 1). SLE, RA, polymyositis, mixed CTD, polymyalgia rheumatica. (2 pts).
Numeric (0 or 1). Peptic ulcer disease requiring treatment. (2 pts).
Numeric (0 or 1). Serum creatinine > 2 mg/dL, dialysis, or renal transplant. (2 pts).
Numeric (0 or 1). DLCO and/or FEV1 66-80% or dyspnea on slight activity. (2 pts).
Numeric (0 or 1). DLCO and/or FEV1 <= 65% or dyspnea at rest/on O2. (3 pts).
Numeric (0 or 1). Prior solid tumor treated at any time point (excluding non-melanoma skin cancer). (3 pts).
Numeric (0 or 1). Moderate to severe valve abnormality (except MVP). (3 pts).
Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106(8):2912-2919. doi:10.1182/blood-2005-05-2004
# Example 1: High Risk
# Diabetes (1), Severe Pulmonary (3)
# Score = 4
hct_ci_score(0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0)
# Example 2: Intermediate Risk
# Obesity (1), Mild Hepatic (1)
# Score = 2
hct_ci_score(0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0)
Run the code above in your browser using DataLab